On Wednesday, June 27, a Denver based federal jury granted $383.5 million to the families of patients who passed away from being treated at DaVita Inc.
Three patients suffering from cardiac arrests went to DaVita Inc. for treatment.
The patients Irma Menchaca, Gary Saldana, and Deborah Hardin were sent to DaVita Inc. for treatment. However, they tragically ended up passing away. The families of these patients then filed a lawsuit against DaVita. They claimed that the company treated the patients improperly, leading to their deaths.
Lawyers representing this case helped the families understand that the hospital used the product GranuFlo on the patients. This product may cause toxic pH imbalances in a patient’s body. Evidently, that imbalance was enough in these cases to kill these patients. After all, they were in a vulnerable place before the deadly treatment.
The jury sided with the plaintiffs, punishing DaVita for the patients’ deaths. The families all got $2 million, $1.5 million and $5 million for compensatory damages. They also received $125 million for punitive damages.
DaVita Inc. Will Appeal
However, despite the jury’s decision, DaVita is appealing and disagrees with the statement that the jurors decided on.
The jury believes that DaVita hid information from the patients about the product, which is why they claimed DaVita guilty of negligence and wrongful death.
In 2012, the U.S. Food and Drug Administration released for their customers to return GranuFlo.
GranuFlo is a product that eliminates bad products in a person’s blood and helps keep a proper pH balance. However, the acetate that is in GranuFlo could cause horrible side effects that lead to a stroke or heart attack, which lawyers explained to the family members of the patients who suffered the side effects.
Families of the patients argued that “DaVita ignored many red flags that preceded the loss of life of these three patients and many others.”